Showing 1–6 of 6 results for author: Kopp-Schneider, A

Information borrowing in Bayesian clinical trials: choice of tuning parameters for the robust mixture prior

Authors: Vivienn Weru, Annette Kopp-Schneider, Manuel Wiesenfarth, Sebastian Weber, Silvia Calderazzo

Abstract: Borrowing historical data for use in clinical trials has increased in recent years. This is accomplished in the Bayesian framework by specification of informative prior distributions. One such approach is the robust mixture prior arising as a weighted mixture of an informative prior and a robust prior inducing dynamic borrowing that allows to borrow most when the current and external data are obse… ▽ More Borrowing historical data for use in clinical trials has increased in recent years. This is accomplished in the Bayesian framework by specification of informative prior distributions. One such approach is the robust mixture prior arising as a weighted mixture of an informative prior and a robust prior inducing dynamic borrowing that allows to borrow most when the current and external data are observed to be similar. The robust mixture prior requires the choice of three additional quantities: the mixture weight, and the mean and dispersion of the robust component. Some general guidance is available, but a case-by-case study of the impact of these quantities on specific operating characteristics seems lacking. We focus on evaluating the impact of parameter choices for the robust component of the mixture prior in one-arm and hybrid-control trials. The results show that all three quantities can strongly impact the operating characteristics. In particular, as already known, variance of the robust component is linked to robustness. Less known, however, is that its location can have a strong impact on Type I error rate and MSE which can even become unbounded. Further, the impact of the weight choice is strongly linked with the robust component's location and variance. Recommendations are provided for the choice of the robust component parameters, prior weight, alternative functional form for this component as well as considerations to keep in mind when evaluating operating characteristics. △ Less

Submitted 4 December, 2024; originally announced December 2024.

Variable selection via fused sparse-group lasso penalized multi-state models incorporating molecular data

Authors: Kaya Miah, Jelle J. Goeman, Hein Putter, Annette Kopp-Schneider, Axel Benner

Abstract: In multi-state models based on high-dimensional data, effective modeling strategies are required to determine an optimal, ideally parsimonious model. In particular, linking covariate effects across transitions is needed to conduct joint variable selection. A useful technique to reduce model complexity is to address homogeneous covariate effects for distinct transitions. We integrate this approach… ▽ More In multi-state models based on high-dimensional data, effective modeling strategies are required to determine an optimal, ideally parsimonious model. In particular, linking covariate effects across transitions is needed to conduct joint variable selection. A useful technique to reduce model complexity is to address homogeneous covariate effects for distinct transitions. We integrate this approach to data-driven variable selection by extended regularization methods within multi-state model building. We propose the fused sparse-group lasso (FSGL) penalized Cox-type regression in the framework of multi-state models combining the penalization concepts of pairwise differences of covariate effects along with transition grouping. For optimization, we adapt the alternating direction method of multipliers (ADMM) algorithm to transition-specific hazards regression in the multi-state setting. In a simulation study and application to acute myeloid leukemia (AML) data, we evaluate the algorithm's ability to select a sparse model incorporating relevant transition-specific effects and similar cross-transition effects. We investigate settings in which the combined penalty is beneficial compared to global lasso regularization. △ Less

Submitted 26 November, 2024; originally announced November 2024.

Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information

Authors: Annette Kopp-Schneider, Manuel Wiesenfarth, Leonhard Held, Silvia Calderazzo

Abstract: Borrowing of information from historical or external data to inform inference in a current trial is an expanding field in the era of precision medicine, where trials are often performed in small patient cohorts for practical or ethical reasons. Many approaches for borrowing from external data have been proposed. Even though these methods are mainly based on Bayesian approaches by incorporating ext… ▽ More Borrowing of information from historical or external data to inform inference in a current trial is an expanding field in the era of precision medicine, where trials are often performed in small patient cohorts for practical or ethical reasons. Many approaches for borrowing from external data have been proposed. Even though these methods are mainly based on Bayesian approaches by incorporating external information into the prior for the current analysis, frequentist operating characteristics of the analysis strategy are of interest. In particular, type I error and power at a prespecified point alternative are in the focus. It is well-known that borrowing from external information may lead to the alteration of type I error rate. We propose a procedure to investigate and report the frequentist operating characteristics in this context. The approach evaluates type I error rate of the test with borrowing from external data and calibrates the test without borrowing to this type I error rate. On this basis, a fair comparison of power between the test with and without borrowing is achieved. △ Less

Submitted 24 February, 2023; originally announced February 2023.

Tree-based exploratory identification of predictive biomarkers in observational data

Authors: Julia Krzykalla, Axel Benner, Annette Kopp-Schneider

Abstract: The idea of "stratified medicine" is an important driver of methodological research on the identification of predictive biomarkers. Most methods proposed so far for this purpose have been developed for the use on randomized data only. However, especially for rare cancers, data from clinical registries or observational studies might be the only available data source. For such data, methods for an u… ▽ More The idea of "stratified medicine" is an important driver of methodological research on the identification of predictive biomarkers. Most methods proposed so far for this purpose have been developed for the use on randomized data only. However, especially for rare cancers, data from clinical registries or observational studies might be the only available data source. For such data, methods for an unbiased estimation of the average treatment effect are well established. Research on confounder adjustment when investigating the heterogeneity of treatment effects and the variables responsible for this is usually restricted to regression modelling. In this paper, we demonstrate how the predMOB, a tree-based method that specifically searches for predictive factors, can be combined with common strategies for confounder adjustment (covariate adjustment, matching, Inverse Probability of Treatment Weighting (IPTW)). In an extensive simulation study, we show that covariate adjustment allows the correct identification of predictive factors in the presence of confounding whereas IPTW fails in situations in which the true predictive factor is not completely independent of the confounding mechanism. A combination of both, covariate adjustment and IPTW performs as well as covariate adjustment alone, but might be more robust in complex settings. An application to the German Breast Cancer Study Group (GBSG) Trial 2 illustrates these conclusions. △ Less

Submitted 16 December, 2022; originally announced December 2022.

Robust incorporation of historical information with known type I error rate inflation

Authors: Silvia Calderazzo, Annette Kopp-Schneider

Abstract: Bayesian clinical trials can benefit of available historical information through the elicitation of informative prior distributions. Concerns are however often raised about the potential for prior-data conflict and the impact of Bayes test decisions on frequentist operating characteristics, with particular attention being assigned to inflation of type I error rates. This motivates the development… ▽ More Bayesian clinical trials can benefit of available historical information through the elicitation of informative prior distributions. Concerns are however often raised about the potential for prior-data conflict and the impact of Bayes test decisions on frequentist operating characteristics, with particular attention being assigned to inflation of type I error rates. This motivates the development of principled borrowing mechanisms, that strike a balance between frequentist and Bayesian decisions. Ideally, the trust assigned to historical information defines the degree of robustness to prior-data conflict one is willing to sacrifice. However, such relationship is often not directly available when explicitly considering inflation of type I error rates. We build on available literature relating frequentist and Bayesian test decisions, and investigate a rationale for inflation of type I error rate which explicitly and linearly relates the amount of borrowing and the amount of type I error rate inflation in one-arm studies. A novel dynamic borrowing mechanism tailored to hypothesis testing is additionally proposed. We show that, while dynamic borrowing prevents the possibility to obtain a simple closed form type I error rate computation, an explicit upper bound can still be enforced. Connections with the robust mixture prior approach, particularly in relation to the choice of the mixture weight and robust component, are made. Simulations are performed to show the properties of the approach for normal and binomial outcomes. △ Less

Submitted 30 November, 2022; originally announced November 2022.

Methods and open-source toolkit for analyzing and visualizing challenge results

Authors: Manuel Wiesenfarth, Annika Reinke, Bennett A. Landman, Manuel Jorge Cardoso, Lena Maier-Hein, Annette Kopp-Schneider

Abstract: Biomedical challenges have become the de facto standard for benchmarking biomedical image analysis algorithms. While the number of challenges is steadily increasing, surprisingly little effort has been invested in ensuring high quality design, execution and reporting for these international competitions. Specifically, results analysis and visualization in the event of uncertainties have been given… ▽ More Biomedical challenges have become the de facto standard for benchmarking biomedical image analysis algorithms. While the number of challenges is steadily increasing, surprisingly little effort has been invested in ensuring high quality design, execution and reporting for these international competitions. Specifically, results analysis and visualization in the event of uncertainties have been given almost no attention in the literature. Given these shortcomings, the contribution of this paper is two-fold: (1) We present a set of methods to comprehensively analyze and visualize the results of single-task and multi-task challenges and apply them to a number of simulated and real-life challenges to demonstrate their specific strengths and weaknesses; (2) We release the open-source framework challengeR as part of this work to enable fast and wide adoption of the methodology proposed in this paper. Our approach offers an intuitive way to gain important insights into the relative and absolute performance of algorithms, which cannot be revealed by commonly applied visualization techniques. This is demonstrated by the experiments performed within this work. Our framework could thus become an important tool for analyzing and visualizing challenge results in the field of biomedical image analysis and beyond. △ Less

Submitted 5 December, 2019; v1 submitted 11 October, 2019; originally announced October 2019.